Hims & Hers Health shares rose Monday after the Food and Drug Administration said compounding pharmacies could continue to ...

One dedicated Chili's fan quickly took to TikTok to show off her preferred lineup: an immaculate display of mozzarella sticks ...

Finely grated chocolate, rolled oats, and chopped walnuts transform the standard chocolate chip cookie recipe into something ...

Snickers is so beloved, that there are copycats out there that attempt to recreate the chocolate bar's flavors. One such ...

In accepting the FDA’s motion, U.S. District Judge Mark Pittman put on hold a lawsuit filed by the Outsourcing Facilities ...

A real estate fraud was averted last week when a Bermuda realtor confirmed to a potential victim that she was about to be ...

Melt 1 cup of butter and allow it to cool for 5 minutes. Add the melted butter, brown sugar and white sugar to a large mixing ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Rival manufacturers fight for the right to sell weight loss drugsThere’s a new fight brewing between ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

There's a hybrid system borrowed from Toyota, plus a copycat "strong hybrid" setup to come from within Mazda eventually, maybe with rotary engine power.

Eli Lilly (LLY) has reportedly sent out cease-and-desist letters to compounding pharmacies and clinics that were providing copycat versions of its drugs Zepbound and Mounjaro.

Eli Lilly & Co. is ramping up its legal campaign against companies that were temporarily allowed to make and sell copycat versions of its blockbuster drugs used for weight loss until a US shortage ...